Pacific Edge’s American dream

Pacific Edge’s American dream
The US Affordable Care Act can be tricky to navigate. (Image: Getty)
Paul McBeth
Pacific Edge has long wanted to crack the United States market, which it has seen for a long time as validating the hundreds of millions spent in developing its Cxbladder non-invasive cancer detection tool. More than 20 years since listing, after it was spun out of University of Otago research, the company has raised $297.23 million selling shares and convertible preference shares and as people exercised options to fund accumulated losses of $216.8m and counting. That’s not going to change any time soon after the company crashed...

More Markets

NZ sharemarket enjoys good week with fourth gain
Markets Market close

NZ sharemarket enjoys good week with fourth gain

The S&P/NZX 50 Index closed at 11,938.08, up 64.04 points or 0.54%.

Graham Skellern 03 May 2024
BHP CEO flies to South Africa to push $65.4 billion takeover
Markets

BHP CEO flies to South Africa to push $65.4 billion takeover

The executives have already begun conversations with key stakeholders.

Bloomberg 03 May 2024
Rakon shareholder wants light shed on $400m bid
Markets

Rakon shareholder wants light shed on $400m bid

US giant Skyworks could be Rakon's new owner. One shareholder wants it to confirm.